It took more than two years, but the Biden administration has finally kept a promise made by then-candidate Joe Biden to roll back the Trump administration’s expansion of short-term, limited-duration health plans. The plans have been controversial because, while they offer lower premiums than more comprehensive health plans, they offer far fewer benefits and are […]
It has been over a decade since whole milk was served in schools through the National School Lunch Program, after U.S. government dietary guidance effectively banned it. But dairy farmers, some health experts, and members of Congress say it’s time to bring it back.
Pharmacy benefit managers, or PBMs, are companies that negotiate the prices of prescription drugs. Hear about their role in raising drug prices and the ongoing efforts to regulate this complex industry.
The number of Californians dying from alcoholic liver disease rose dramatically in the last decade, sped by the pandemic.
It is illegal to help a minor obtain an abortion in Idaho or leave the state for one without parental consent. The lawsuit says the ban infringes on the right to interstate travel and First Amendment freedoms.
As three years of pandemic stress accelerated an ongoing nationwide mental health crisis, peer respite programs diverted patients from overburdened emergency rooms, psychiatric institutions, and behavioral therapists. Now, more “respites” are opening.
Nonprofit hospitals avoid paying taxes if they provide community benefits such as charity care. More states are examining that trade-off, scrutinizing the extent of hospitals’ spending on their communities.
At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients.
A proposed Environmental Protection Agency rule calls for companies to disclose PFAS manufactured or imported since 2011. The chemical industry is upset because such compliance would cost an estimated $1 billion, while environmental health advocates worry because the rule wouldn’t ban the chemicals outright.
As settlement dollars land at the state level, state councils wield significant power in determining how the windfall gets spent. And, though they will likely include the most knowledgeable voices on addiction, these panels also face concerns about conflicts of interest and other issues.
